FDA Drug Application (204311) for ABACAVIR AND LAMIVUDINE by MYLAN LABS LTD

Back to FDA Applications sponsored by MYLAN LABS LTD

Application Number204311
Product Number001
FormTABLET, FOR SUSPENSION;ORAL
Dosage60MG;30MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameABACAVIR AND LAMIVUDINE
Active IngredientABACAVIR;LAMIVUDINE

Active IngredientCount
List of drugs with Active Ingredient ABACAVIR4
List of drugs with Active Ingredient LAMIVUDINE39


Back to FDA Applications sponsored by MYLAN LABS LTD